Showing 4,441 - 4,460 results of 18,433 for search 'significant ((((((a decrease) OR (step decrease))) OR (we decrease))) OR (mean decrease))', query time: 0.63s Refine Results
  1. 4441

    Table 4_Epizootic shell disease induces systemic transcriptomic shifts in Homarus americanus, characterized by increased shell degradation and impaired energy metabolism across tis... by Minseo Kim (773205)

    Published 2025
    “…In a previous study, we found that the microbiome composition of the carapace in lobsters with ESD differed from that of healthy individuals, with ESD-associated bacteria enriched in the green gland and testis. …”
  2. 4442

    Table 3_Epizootic shell disease induces systemic transcriptomic shifts in Homarus americanus, characterized by increased shell degradation and impaired energy metabolism across tis... by Minseo Kim (773205)

    Published 2025
    “…In a previous study, we found that the microbiome composition of the carapace in lobsters with ESD differed from that of healthy individuals, with ESD-associated bacteria enriched in the green gland and testis. …”
  3. 4443

    Table 2_Epizootic shell disease induces systemic transcriptomic shifts in Homarus americanus, characterized by increased shell degradation and impaired energy metabolism across tis... by Minseo Kim (773205)

    Published 2025
    “…In a previous study, we found that the microbiome composition of the carapace in lobsters with ESD differed from that of healthy individuals, with ESD-associated bacteria enriched in the green gland and testis. …”
  4. 4444

    Table 7_Epizootic shell disease induces systemic transcriptomic shifts in Homarus americanus, characterized by increased shell degradation and impaired energy metabolism across tis... by Minseo Kim (773205)

    Published 2025
    “…In a previous study, we found that the microbiome composition of the carapace in lobsters with ESD differed from that of healthy individuals, with ESD-associated bacteria enriched in the green gland and testis. …”
  5. 4445

    Table 5_Epizootic shell disease induces systemic transcriptomic shifts in Homarus americanus, characterized by increased shell degradation and impaired energy metabolism across tis... by Minseo Kim (773205)

    Published 2025
    “…In a previous study, we found that the microbiome composition of the carapace in lobsters with ESD differed from that of healthy individuals, with ESD-associated bacteria enriched in the green gland and testis. …”
  6. 4446

    Loxoprofen or SB225002 administration attenuated inflammatory pain in complete Freund’s adjuvant (CFA)-injected mice exposed to sound stress. by Satoka Kasai (3861115)

    Published 2025
    “…<b>(A)</b> Loxoprofen administration (500 mg/kg) significantly decreased the response times to filament in CFA + saline group 60 min after administration (***<i>P</i> < 0.001), and in CFA + stress + saline group (30 and 60 min after administration, **<i>P</i> < 0.01). …”
  7. 4447
  8. 4448
  9. 4449
  10. 4450
  11. 4451
  12. 4452
  13. 4453
  14. 4454

    Valve closing capability and hemolymph flow analysis. by Christian Meyer (6035)

    Published 2025
    “…(J) Analysis of hemolymph flow in the aorta. Mean pixel intensity of the dye package is significantly reduced upon valve malformation, indicating less hemolymph is pumped (Scheme illustrates dye package in the aorta and its area analyzed). …”
  15. 4455
  16. 4456

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer by Jiaxing Li (113609)

    Published 2025
    “…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …”
  17. 4457

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer by Jiaxing Li (113609)

    Published 2025
    “…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …”
  18. 4458

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer by Jiaxing Li (113609)

    Published 2025
    “…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …”
  19. 4459

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer by Jiaxing Li (113609)

    Published 2025
    “…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …”
  20. 4460